![Hugh MacNaught](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 29 675 $ al 31/07/2026
Mr. Hugh MacNaught is a President, Chief Executive Officer & Director at VentriPoint Diagnostics Ltd. and a Chief Executive Officer at Nanologix Research, Inc. He is on the Board of Directors at VentriPoint Diagnostics Ltd. Mr. MacNaught was previously employed as an Executive Vice President by biOasis Technologies, Inc.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 08/07/2026 | 375.634 ( 0,19 % ) | 29 675 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| VENTRIPOINT DIAGNOSTICS LTD. | Director Ejecutivo | 05/02/2024 |
Nanologix Research, Inc. | Director Ejecutivo | - |
| Empresas | Cargo | Fin |
|---|---|---|
| VENTRIPOINT DIAGNOSTICS LTD. | Director/Miembro de la Junta | 01/10/2020 |
| BIOASIS TECHNOLOGIES INC. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
VentriPoint Diagnostics Ltd.
 VentriPoint Diagnostics Ltd. Medical SpecialtiesHealth Technology Manufactures cardiac imaging systems | Health Technology |
biOasis Technologies, Inc.
 biOasis Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutic drug delivery for the treatment of neurological diseases and disorders | Health Technology |
Nanologix Research, Inc. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
